Telehealth Cognitive Behavioral Therapy for Alcohol Abuse with Cardiovascular Risk
(ACME-TM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to assist veterans who struggle with alcohol use and face heart disease risks, such as high blood pressure or diabetes. It combines online therapy sessions with daily text messages to reduce alcohol use and improve heart health. This approach, known as Alcohol and CVD Management and Engagement through Telehealth and mHealth (ACME-TM), provides support through telehealth cognitive behavioral therapy. Participants must have alcohol-related issues and heart risk factors, like uncontrolled high blood pressure, and must own a phone capable of receiving text messages. The goal is to determine if these methods are user-friendly and beneficial for both veterans and their doctors. As an unphased trial, this study offers veterans the chance to explore innovative support methods that could enhance their health and well-being.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you must be on an appropriate medication regimen for cardiovascular disease prevention, which will be reviewed by a research coordinator and a doctor.
What prior data suggests that this intervention is safe for alcohol misuse and cardiovascular risk?
Research shows that telehealth cognitive behavioral therapy (CBT) for alcohol misuse is generally safe. Studies have found that digital CBT can help people stop drinking without causing serious harm.
Safety information specifically about telehealth indicates that serious problems are rare. However, not all studies reported detailed information about any issues, so while problems are uncommon, they might not be fully documented.
Overall, telehealth treatments, including CBT, appear to be well-tolerated. Participants in these studies did not report major negative effects, suggesting the treatment is safe for most people, though individual experiences might differ. Discussing any concerns with the clinical team is always advisable.12345Why are researchers excited about this trial?
Researchers are excited about the ACME-TM treatment because it combines telehealth cognitive behavioral therapy (CBT) with daily mobile health (mHealth) support to tackle both alcohol misuse and cardiovascular risk. Unlike traditional face-to-face therapy sessions and medication, this approach leverages technology to provide accessible, real-time support, making it easier for participants to integrate into their daily lives. The addition of daily text messages for a month also offers continuous engagement and motivation, which is a novel way to help reduce cardiovascular risk factors alongside alcohol use. This dual-focus and tech-driven delivery method could represent a significant advancement in treating these conditions concurrently.
What evidence suggests that this telehealth CBT is effective for alcohol misuse and cardiovascular risk?
Research has shown that online therapy, known as telehealth cognitive behavioral therapy (CBT), can effectively help people struggling with alcohol misuse. In this trial, participants will receive the ACME-TM treatment, which includes telehealth CBT sessions focused on reducing alcohol misuse. Studies have found that telehealth CBT makes it easier for people to access the help they need and has shown promise in reducing alcohol consumption. Combining telehealth with text messages can also encourage healthier habits, which may help manage heart health risks. This method might particularly benefit people with high blood pressure, as reducing alcohol intake can help lower blood pressure. While research is ongoing, early results suggest that this approach could reduce alcohol misuse and improve heart health.16789
Who Is on the Research Team?
Daniel Blalock, PhD
Principal Investigator
Durham VA Medical Center, Durham, NC
Are You a Good Fit for This Trial?
This trial is for Veterans with uncontrolled high blood pressure, hyperlipidemia, or diabetes who misuse alcohol. They must be enrolled in specific VA clinics, have a history of these conditions for at least a year, take medication for them, and have access to text messaging. Excluded are those in other CVD or alcohol treatment trials, with severe alcohol dependence or significant withdrawal symptoms.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 4 sessions of telehealth cognitive behavioral therapy (CBT) focused on reducing alcohol misuse, followed by a 5th telehealth coaching call to develop a plan for cardiovascular risk factors. Participants then receive daily texts for one month aimed at helping them decrease these cardiovascular risk factors.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of treatment acceptability and SMS text acceptability.
Long-term Follow-up
Participants' systolic blood pressure and self-reported heavy drinking days are monitored to assess long-term outcomes.
What Are the Treatments Tested in This Trial?
Interventions
- Alcohol and CVD Management and Engagement through Telehealth and mHealth (ACME-TM)
Alcohol and CVD Management and Engagement through Telehealth and mHealth (ACME-TM) is already approved in United States for the following indications:
- Alcohol misuse
- Cardiovascular disease risk reduction
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor